Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 5/1999

01-07-1999

Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials

Authors: Sara J. Prest, Robert C. Rees, Craig Murdoch, John F. Marshall, Patricia A. Cooper, Michael Bibby, Geng Li, Selman A. Ali

Published in: Clinical & Experimental Metastasis | Issue 5/1999

Login to get access
Metadata
Title
Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials
Authors
Sara J. Prest
Robert C. Rees
Craig Murdoch
John F. Marshall
Patricia A. Cooper
Michael Bibby
Geng Li
Selman A. Ali
Publication date
01-07-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 5/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006657109866

Other articles of this Issue 5/1999

Clinical & Experimental Metastasis 5/1999 Go to the issue

OriginalPaper

Resistance to apoptosis induced by microenvironmental stresses is correlated with metastatic potential in Lewis lung carcinoma

OriginalPaper

Alterations in proteolytic activity at low pH and its association with invasion: A theoretical model

OriginalPaper

Multi-organ metastatic capability of Chinese hamster ovary cells revealed by green fluorescent protein (GFP) expression

OriginalPaper

Matrix metalloproteinase 9 is induced by the Epstein–Barr virus BZLF1 transactivator

OriginalPaper

N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cells

OriginalPaper

Induction of c-met proto-oncogene expression at the metastatic site
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits